Chronic infection and severe mitral regurgitation: first of all, do not harm.

Autor: Pozzi A; Cardiology Department, Valduce Hospital, Como, Italy. andreawellsvabg@gmail.com., Bartesaghi G; Cardiology Department, Valduce Hospital, Como, Italy., Berlinghieri N; Cardiology Department, Valduce Hospital, Como, Italy., Bonfanti P; Cardiology Department, Valduce Hospital, Como, Italy., Refugjati T; Cardiology Department, Valduce Hospital, Como, Italy., Foglia-Manzillo G; Cardiology Department, Valduce Hospital, Como, Italy., Esposito G; Cardiac Surgery Department, Monzino Hospital, Milan, Italy., Corrado G; Cardiology Department, Valduce Hospital, Como, Italy.
Jazyk: angličtina
Zdroj: The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2024 Dec; Vol. 40 (12), pp. 2635-2639. Date of Electronic Publication: 2024 Oct 26.
DOI: 10.1007/s10554-024-03267-9
Abstrakt: techniques of mitral valve repair has improved in the last decades. Percutaneous approach is now a reliable and safe therapy in those patients with high surgical risk. However, the presence of an implanted prothesis increases the risk of endocarditis. we describe a case of a 75-year-old man with medical history of recurrent cellulitis due to chronic lymphedema, who had percutaneous edge-to-edge mitral valve treatment. After three months he developed fever without any specific symptoms. Emocolture were positive for Staphilococcus lugdunensis. Transesophageal echocardiogram demonstrated a huge vegetation at the level of Edwards Pascal device. Patients was then referred to cardiac surgery for mitral valve replacement with bioprothesis. in patients needing a prothesis implantation the management and treatment of chronic infection is of paramount importance to reduce the risk of prothesis infection procedure. Endocarditis after percutaneous edge-to-edge mitral valve treatment represents a rare but a life-threatening condition.
Competing Interests: Declarations. Competing interests: The authors declare no competing interests.
(© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
Databáze: MEDLINE